These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7060312)
1. Cardiocirculatory actions of trimazosin and sodium nitroprusside in ischemic heart disease. Awan NA; Hermanovich J; Vera Z; Amsterdam EA; Mason DT Clin Pharmacol Ther; 1982 Mar; 31(3):290-6. PubMed ID: 7060312 [TBL] [Abstract][Full Text] [Related]
2. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance. Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013 [TBL] [Abstract][Full Text] [Related]
3. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure. Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the hemodynamic actions of captopril and sodium nitroprusside in severe chronic congestive heart failure. Hermanovich J; Awan NA; Lui H; Mason DT Am Heart J; 1982 Nov; 104(5 Pt 2):1211-4. PubMed ID: 6753551 [TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure. Awan NA; Miller RR; Mason DT Circulation; 1978 Jan; 57(1):152-9. PubMed ID: 618383 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation. Miller RR; Vismara LA; Williams DO; Amsterdam EA; Mason DT Circ Res; 1976 Jul; 39(1):127-33. PubMed ID: 819179 [TBL] [Abstract][Full Text] [Related]
7. Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction. Miller RR; Awan NA; Joye JA; Maxwell KS; DeMaria AN; Amsterdam EA; Mason DT Circulation; 1977 Jun; 55(6):881-4. PubMed ID: 858184 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy. Dei Cas L; Fappani A; Riva S; Metra M; Cicogna R; Manca C; Visioli O Clin Cardiol; 1985 Aug; 8(8):427-32. PubMed ID: 4028536 [TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of trimazosin in patients with left ventricular failure. Franciosa JA; Cohn JN Clin Pharmacol Ther; 1978 Jan; 23(1):11-8. PubMed ID: 618705 [TBL] [Abstract][Full Text] [Related]
11. Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure. Elkayam U; Weber L; Torkan B; McKay CR; Rahimtoola SH Am J Cardiol; 1984 May; 53(9):1321-5. PubMed ID: 6711434 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective. Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573 [TBL] [Abstract][Full Text] [Related]
13. [Comparative hemodynamic effect of sodium nitroprusside and prazosin hydrochloride in patients with cardiac insufficiency following acute myocardial infarction]. López-Sendón J; Coma Canella I Rev Esp Cardiol; 1981; 34(1):55-61. PubMed ID: 7280350 [No Abstract] [Full Text] [Related]
14. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin. Awan NA; Beattie JM; Evenson ME; Needham KE; Mason DT J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S176-80. PubMed ID: 6175836 [TBL] [Abstract][Full Text] [Related]
15. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure. Mikulic E; Cohn JN; Franciosa JA Circulation; 1977 Oct; 56(4 Pt 1):528-33. PubMed ID: 902377 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography. Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789 [TBL] [Abstract][Full Text] [Related]
17. Assessment of vasodilator therapy in patients with severe congestive heart failure: limitations of measurements of left ventricular ejection fraction and volumes. Firth BG; Dehmer GJ; Markham RV; Willerson JT; Hillis LD Am J Cardiol; 1982 Nov; 50(5):954-9. PubMed ID: 6291370 [TBL] [Abstract][Full Text] [Related]
18. Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosin. Packer M; Meller J; Gorlin R; Herman MV Am J Cardiol; 1979 Aug; 44(2):310-7. PubMed ID: 463769 [TBL] [Abstract][Full Text] [Related]
19. Intravenous fenoldopam in heart failure: comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprusside. Young JB; Leon CA; Pratt CM; Kingry C; Taylor AA; Roberts R Am Heart J; 1988 Feb; 115(2):378-84. PubMed ID: 2893527 [TBL] [Abstract][Full Text] [Related]